CTXR
Price
$0.53
Change
-$0.01 (-1.85%)
Updated
Oct 2 closing price
Capitalization
15.07M
74 days until earnings call
Intraday BUY SELL Signals
EYPT
Price
$3.25
Change
+$0.02 (+0.62%)
Updated
Oct 2 closing price
Capitalization
285.36M
31 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTXR vs EYPT

CTXR vs EYPT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CTXR vs. EYPT commentary
Oct 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Hold and EYPT is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CTXR vs EYPT: Fundamental Ratings
CTXR
EYPT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
8096
P/E GROWTH RATING
1..100
10013
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTXR's Valuation (5) in the Pharmaceuticals Major industry is significantly better than the same rating for EYPT (75). This means that CTXR’s stock grew significantly faster than EYPT’s over the last 12 months.

CTXR's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as EYPT (100). This means that CTXR’s stock grew similarly to EYPT’s over the last 12 months.

CTXR's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as EYPT (99). This means that CTXR’s stock grew similarly to EYPT’s over the last 12 months.

CTXR's Price Growth Rating (80) in the Pharmaceuticals Major industry is in the same range as EYPT (96). This means that CTXR’s stock grew similarly to EYPT’s over the last 12 months.

EYPT's P/E Growth Rating (13) in the Pharmaceuticals Major industry is significantly better than the same rating for CTXR (100). This means that EYPT’s stock grew significantly faster than CTXR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTXREYPT
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
COMPARISON
Comparison
Oct 05, 2026
Stock price -- (CTXR: $0.53 vs. EYPT: $3.25)
Brand notoriety: CTXR and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 13% vs. EYPT: 63%
Market capitalization -- CTXR: $15.07M vs. EYPT: $285.36M
CTXR [@Biotechnology] is valued at $15.07M. EYPT’s [@Biotechnology] market capitalization is $285.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green while EYPT’s FA Score has 1 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, both CTXR and EYPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 3 TA indicator(s) are bullish while EYPT’s TA Score has 5 bullish TA indicator(s).

  • CTXR’s TA Score: 3 bullish, 6 bearish.
  • EYPT’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than CTXR.

Price Growth

CTXR (@Biotechnology) experienced а -8.12% price change this week, while EYPT (@Biotechnology) price change was -10.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.69%. For the same industry, the average monthly price growth was -14.41%, and the average quarterly price growth was -1.73%.

Reported Earning Dates

CTXR is expected to report earnings on Dec 17, 2026.

EYPT is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (-3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CTXR
Daily Signal:
Gain/Loss:
EYPT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LSGR45.310.46
+1.03%
Natixis Loomis Sayles Focused Growth ETF (LSGR)
DEMZ49.190.34
+0.69%
Democratic Large Cap Core ETF (DEMZ)
SPYV61.480.24
+0.39%
State Street SPDR Portfolio S&P 500 Value ETF (SPYV)
FXD64.590.10
+0.15%
First Trust Consumer Discretionary AlphaDEX Fund (FXD)
RNEM54.800.08
+0.15%
First Trust Emerging Markets Equity Select ETF (RNEM)

CTXR and

Correlation & Price change

A.I.dvisor tells us that CTXR and MGX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTXR and MGX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
-1.23%
MGX - CTXR
32%
Poorly correlated
-7.69%
ALEC - CTXR
31%
Poorly correlated
-2.69%
PRQR - CTXR
31%
Poorly correlated
+0.31%
TWST - CTXR
29%
Poorly correlated
+0.33%
EYPT - CTXR
29%
Poorly correlated
+0.62%
More

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with ATHE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then ATHE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+0.62%
ATHE - EYPT
54%
Loosely correlated
-6.52%
KROS - EYPT
40%
Loosely correlated
+0.89%
AMLX - EYPT
38%
Loosely correlated
-1.03%
KYTX - EYPT
37%
Loosely correlated
-4.60%
VTGN - EYPT
37%
Loosely correlated
-0.57%
More